跳至主要内容
临床试验/NCT05686265
NCT05686265终止不适用

Cerebral Nitrosative/Oxidative Stress in Aneurysmal Subarachnoid Haemorrhage

Rigshospitalet, Denmark1 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2023年5月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
3
试验地点
1
主要终点
Transcerebral exchange of bioactive NO, patients vs. controls

研究概览

简要总结

Aneurysmal subarachnoid haemorrhage (SAH) carries a high morbidity and mortality, which is in part due to the development of secondary brain injury. The mechanisms behind this remain incompletely understood, but oxidative/nitrosative stress and disturbances in vasoregulatory mechanisms are believed to be involved. The present study aims to characterise the transcerebral exchange of oxidative/nitrosative stress markers and nitric oxide metabolites during the early phase after SAH compared to healthy volunteers, including the influence of induced changes in arteriel oxygen tension.

详细描述

BACKGROUND:

Aneurysmal subarachnoid haemorrhage (SAH) carries a high morbidity and mortality. This is in large part due to the development of secondary brain injury, including the complication delayed cerebral ischaemia (DCI), which affects 30% of initial survivors. The mechanisms behind secondary brain injury after SAH are incompletely understood.

Nitric oxide (NO) is a potent endogenous vasodilator produced from arginine by the enzyme nitric oxide synthase (NOS), which exists in three isoforms: endothelial, neuronal, and inducible NOS (eNOS, nNOS and iNOS). In conditions of inflammation and oxidative stress, free radicals may react with NO to form peroxynitrite (ONOO-), which is highly reactive and can directly damage biological macromolecules such as lipids and proteins. This phenomenon, i.e. an increased production of reactive nitrogen species potentially leading to cellular damage, is termed nitrosative stress.

It is widely believed that oxidative/nitrosative stress and associated disturbances in the metabolism of NO are involved in the development of secondary brain injury after SAH, but the exact role of these mechanisms remains incompletely understood. While some authors believe that NOS dysfunction and a resultant low NO bioavailability is an important cause of secondary brain injury (and a key mechanism behind DCI), others argue that an overproduction of NO mediated by iNOS is maladaptive response leading to aggravated tissue injury due to nitrosative stress.

The transcerebral (i.e., arterial to jugular venous) exchange of NO metabolites and its interrelationship with oxidative stress has never been studied in patients with SAH. The investigators hypothesise that SAH is associated with an initial reduction in the cerebrovascular bioavailability of NO due to scavenging by free radicals. This could contribute to a vicious cycle, in which a resulting increase in microvascular resistance, cerebral hypoperfusion, and brain tissue hypoxia further increases free radical production and NO depletion, ultimately leading to ischaemic brain injury and poor outcome.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Patients

Patients with SAH (see eligibility criteria below).

干预措施: Oxygen (Drug)

Controls

Healthy controls (see eligibility criteria below).

干预措施: Oxygen (Drug)

结局指标

主要结局

Transcerebral exchange of bioactive NO, patients vs. controls

时间窗: At baseline

Transcerebral exchange of bioactive NO (plasma nitrite + S-nitrosothiols) (nM) in patients vs. controls.

Transcerebral exchange of oxidative stress markers, patients vs. controls

时间窗: At baseline

Transcerebral exchange of the ascorbate radical (μM) in patients vs. healthy controls.

Transcerebral exchange of nitrosative stress markers, patients vs. controls

时间窗: At baseline

Transcerebral exchange of 3-nitrotyrosine (nM) in patients vs. healthy controls.

次要结局

  • Transcerebral exchange of nitrosative/oxidative stress markers, effects of hypo-/hyperoxia(Within one week)
  • Transcerebral exchange of nitrosative/oxidative stress markers, changes over time(Within one week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anton Lund

Principal Investigator

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验